Akhavan, D., Yadav, M., Subham, S., Jeppson, J., Tinoco, O., Chin, S., Santana-Magal, N., Babai, J., Szarejko, J., Gibson, G., Sabitov, K., Zamler, D. B, Myers, G. D, Fridley, B. L, Bossmann, S. H, Pyaram, K., Yadav, V. N (2026). Potent anti-tumor preclinical efficacy of B7-H3 CAR-T cells in H3G34-mutant, Diffuse Hemispheric Glioma. Neuro-oncology. doi: 10.1093/neuonc/noag185. Online ahead of print.

Tripathi A, Dasgupta D, Burt E, Santana-Magal N, Wood R, Taylor JA, Bossmann SH, Weir SJ, Pyaram K. (2026). Ciclopirox Modulates Notch Activation and Effector Responses in Activated Human T Cells. iScience. May 25;29(6)

Tripathi A, Dasgupta D, Ahuja M, Fisette G, Santana-Magal N, Pyaram K. (2026) Protocol for intranuclear Nrf2 detection in activated mouse, human, and Jurkat T cells by spectral flow cytometry. STAR Protoc. 2026 Feb 11;7(1):104360.

Prasad C, Dasgupta D, Tripathi A, Steele N, Pyaram K* and Sundar IK* (2025). Dietary Influence on Lung Injury and Immune Modulation in Cadmium-Exposed Mice. Am J Physiol Lung Cell Mol Physiol. 2025 Nov 1;329(5): L642-L657. (*co-senior authors).

Tripathi A, Dasgupta D, Dahabieh MS, Griffard-Smith R, Pant A, Bugbee A, Yellapu NK, Burt E, Choi BHY, Ellis AE, Sheldon RD, Giri S, Koestler D, Jones RG, Yadav VN and Pyaram K (2025). Nrf2 drives the activation-driven expansion of CD4 + T-cells by modulating glucose and glutamine metabolism. Cell Reports 2025. Sep 23;44(9):116177.

Dasgupta D, Tripathi A, Griffard-Smith R, Yellapu NK, Dhorajiya P, Pyaram K (2025) Therapeutic Potential of NRF2 activating drug RTA-408 in suppressing T-cell effector responses and inflammatory bowel disease. J Immunol. 2025 Aug 1;214(8):1951-1968.

Prasad C, Dasgupta D, Tripathi A, Steele N, Pyaram K* and Sundar IK* (2024) Cadmium-induced lung

injury disrupts immune cell homeostasis in the secondary lymphoid organs in mice. Toxicology, 2024, Dec;509:153971. (*co-senior authors).

Pyaram K* and Chang CH*. (2024) NKT cells and other innate T cells: the immune cells that do not follow the rules. J Immunol. 2024, 213: 1-3. (*co-senior authors).

Pant A, Dasgupta D, Tripathi A, and Pyaram K. (2023) Beyond Antioxidation: Keap1–Nrf2 in the Development and Effector Functions of Adaptive Immune Cells. ImmunoHorizons, 2023 Apr 1;7(4):288-298

Qin T, Mullan B, Ravindran R, Messinger D, Siada R, Cummings JR, Harris M, Muruganand A, Pyaram K, Miklja Z, Reiber M, Garcia T, Tran D, Danussi C, Brosnan-Cashman J, Pratt D, Zhao X, Rehemtulla A, Sartor MA, Venneti S, Meeker AK, Huse JT, Morgan MA, Lowenstein PR, Castro MG, Yadav VN, Koschmann C. (2022) ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization. Cell Reports. 2022 Jan 11;38(2):110216. 

Pyaram K*, Kumar A, Kim YH, Noel S, Reddy SP, Rabb H and Chang CH*. (2019) Keap1-Nrf2 system plays an essential role for Invariant Natural Killer T cell development and homeostasis. Cell Reports. 2019 Apr 16;27(3), p699-707. (*co-senior authors).

Kumar A, Pyaram K, Yarosz E, Hong H, Lyssiotis CA, Giri S and Chang CH. (2019) Enhanced oxidative phosphorylation by PLZF is essential for survival and function of NKT cells. Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7439-7448.

Pyaram K* and Yadav VN* (2018). Advances in NKT cell Immunotherapy for Glioblastoma. J Cancer Sci Ther. 2018;10(6). pii: 533. doi: 10.4172/1948-5956.1000533 (*co-senior authors).

Kim YH, Kumar A, Chang CH and Pyaram K. (2017) Reactive Oxygen Species Regulate the Inflammatory Function of NKT Cells through Promyelocytic Leukemia Zinc Finger. J Immunol. 2017 Nov 15;199(10):3478-3487.

Pyaram K, Sen JM, Chang CH. (2016) Temporal regulation of Wnt/β-Catenin signaling is important for Invariant NKT Cell development and Terminal Maturation. Mol Immunol. Feb 13;85:47-56.

Shin J, Maekawa T, Abe T, Hajishengallis E, Hosur K, Pyaram K, Mitroulis I, Chavakis T, Hajishengallis G. (2015) DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates. Sci Transl Med. 307(7) pp. 307ra155

Prevot N, Pyaram K, Bischoff E, Sen JM, Powell JD, Chang CH. (2015) Mammalian target of rapamycin complex 2 regulates invariant NKT cell development and function independent of promyelocytic leukemia zinc-finger. J Immunol. 194(1):223-30

Yadav VN, Pyaram K, Ahmad M and Sahu A. (2012) Species selectivity in poxviral complement regulators is dictated by the charge reversal in the central complement control protein modules. J. Immunol. 189(3): 1431-1439

Pyaram K, Kieslich CA, Yadav VN, Morikis D and Sahu A (2010). Influence of electrostatics on the complement regulatory functions of Kaposica, the complement inhibitor of Kaposi’s sarcomaassociated herpesvirus. J. Immunol. 184: 1956-1967.

Pyaram K, Yadav VN, Reza MJ, and Sahu A (2010). Virus-complement interaction: an assiduous struggle for dominance. Future Virology. 5: 709-730

Yadav VN, Pyaram K, Mullick J and Sahu A. (2008). Identification of hot spots in variola virus complement inhibitor (SPICE) for human complement regulation. J. Virol. 82: 3283-3294.

Ahmad M, Pyaram K, Mullick J and Sahu A. (2007). Viral complement regulators: the expert mimicking swindlers. Ind. J. Biochem. Biophy. 44: 331-343